Molecular-glue-mediated proximity-induced degradation now allows unprecedented therapeutic targeting of previously undruggable proteins. Structures showing how aryl-sulfonamides mediate recruitment of the splicing factor RBM39 to the E3 CRL4DCAF15 broaden the mechanistic principles by which molecular glues target ubiquitylation.
Your institute does not have access to this article
Access options
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$119.00
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Tan, X. et al. Nature 446, 640–645 (2007).
Krönke, J. et al. Science 343, 301–305 (2014).
Lu, G. et al. 343, 305–309 (2014).
Petzold, G., Fischer, E. S. & Thomä, N. H. Nature 532, 127–130 (2016).
Faust, T. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-019-0378-3 (2019).
Bussiere, D. E. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-019-0411-6 (2019).
Du, X. et al. Structure 27, 1625–1633.e3 (2019).
Han, T. et al. Science 356, eaal3755 (2017).
Uehara, T. et al. Nat. Chem. Biol. 13, 675–680 (2017).
Nowak, R. P. et al. Nat. Chem. Biol. 14, 706–714 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Baek, K., Schulman, B.A. Molecular glue concept solidifies. Nat Chem Biol 16, 2–3 (2020). https://doi.org/10.1038/s41589-019-0414-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-019-0414-3
Further reading
-
Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy
Medicinal Chemistry Research (2022)
-
Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy
Oncogene (2020)
-
Anticancer strategies by upregulating p53 through inhibition of its ubiquitination by MDM2
Medicinal Chemistry Research (2020)